Upstream effect for atrial fibrillation: still a dilemma?
Calò
Leonardo
L
Division of Cardiology, Policlinico Casilino ASL RMB, Rome, Italy.
Martino
Annamaria
A
Sciarra
Luigi
L
Ciccaglioni
Antonio
A
De Ruvo
Ermenegildo
E
De Luca
Lucia
L
Sette
Antonella
A
Giunta
Giuseppe
G
Lioy
Ernesto
E
Fedele
Francesco
F
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D015525:Fatty Acids, Omega-3; D005938:Glucocorticoids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors